v3.26.3
Significant Accounting Policies - Schedule of Fair Value Measurements on a Recurring Basis (Details) - Fair Value, Recurring [Member] - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Investments at fair value (see note 4):    
Investments at fair value   $ 164,270
Investment in associate at fair value- Lifeward (see note 9):    
Investment in associates at fair value $ 360,044  
DNA [Member]    
Marketable Securities (see note 3):    
Marketable Securities 583 540
Entera [Member]    
Marketable Securities (see note 3):    
Marketable Securities   227
Pelthos [Member]    
Marketable Securities (see note 3):    
Marketable Securities   4,650
Nano [Member]    
Marketable Securities (see note 3):    
Marketable Securities 10,801 8,371
Ruby Capital [Member]    
Investments at fair value (see note 4):    
Investments at fair value 449  
Scilex Royalty Purchase Agreement [Member]    
Investments at fair value (see note 4):    
Investments at fair value 1,749 2,209
Scilex Tranche A Note [Member]    
Investments at fair value (see note 4):    
Investments at fair value 18,716 23,063
Scilex Tranche B Note [Member]    
Investments at fair value (see note 4):    
Investments at fair value 4,591 11,473
Scilex Warrants Note B [Member]    
Investments at fair value (see note 4):    
Investments at fair value 97 850
Investment in Alpha Tau's warrants [Member]    
Investments at fair value (see note 4):    
Investments at fair value 36,626 6,242
Warren at Bay Loan [Member]    
Investments at fair value (see note 4):    
Investments at fair value 2,703  
83 Wythe Loan [Member]    
Investments at fair value (see note 4):    
Investments at fair value 2,341  
Profit Sharing Loan Agreement [Member]    
Investments at fair value (see note 4):    
Investments at fair value 3,338 1,890
Loan agreement measured in fair value [Member]    
Investments at fair value (see note 4):    
Investments at fair value 37,883 27,943
Investment in Alpha Tau's shares [Member]    
Investments at fair value (see note 4):    
Investments at fair value 215,739 71,623
Loan to an equity method investee [Member]    
Investments at fair value (see note 4):    
Investments at fair value 4 553
Convertible note [Member]    
Investments at fair value (see note 4):    
Investments at fair value   4,636
Investment in Shares [Member]    
Investment in associate at fair value- Lifeward (see note 9):    
Investment in associates at fair value 8,252  
Investment in A&R Pre-Funded Warrants [Member]    
Investment in associate at fair value- Lifeward (see note 9):    
Investment in associates at fair value 6,640  
Investment in A&R Warrants [Member]    
Investments at fair value (see note 4):    
Investments at fair value 1,675  
Investment in A&R Note and Note Warrants [Member]    
Investments at fair value (see note 4):    
Investments at fair value 7,857  
Level 1 [Member]    
Investments at fair value (see note 4):    
Investments at fair value   85,411
Investment in associate at fair value- Lifeward (see note 9):    
Investment in associates at fair value 235,375  
Level 1 [Member] | DNA [Member]    
Marketable Securities (see note 3):    
Marketable Securities 583 540
Level 1 [Member] | Entera [Member]    
Marketable Securities (see note 3):    
Marketable Securities   227
Level 1 [Member] | Pelthos [Member]    
Marketable Securities (see note 3):    
Marketable Securities   4,650
Level 1 [Member] | Nano [Member]    
Marketable Securities (see note 3):    
Marketable Securities 10,801 8,371
Level 1 [Member] | Ruby Capital [Member]    
Investments at fair value (see note 4):    
Investments at fair value  
Level 1 [Member] | Scilex Royalty Purchase Agreement [Member]    
Investments at fair value (see note 4):    
Investments at fair value
Level 1 [Member] | Scilex Tranche A Note [Member]    
Investments at fair value (see note 4):    
Investments at fair value
Level 1 [Member] | Scilex Tranche B Note [Member]    
Investments at fair value (see note 4):    
Investments at fair value
Level 1 [Member] | Scilex Warrants Note B [Member]    
Investments at fair value (see note 4):    
Investments at fair value
Level 1 [Member] | Investment in Alpha Tau's warrants [Member]    
Investments at fair value (see note 4):    
Investments at fair value
Level 1 [Member] | Warren at Bay Loan [Member]    
Investments at fair value (see note 4):    
Investments at fair value  
Level 1 [Member] | 83 Wythe Loan [Member]    
Investments at fair value (see note 4):    
Investments at fair value  
Level 1 [Member] | Profit Sharing Loan Agreement [Member]    
Investments at fair value (see note 4):    
Investments at fair value
Level 1 [Member] | Loan agreement measured in fair value [Member]    
Investments at fair value (see note 4):    
Investments at fair value
Level 1 [Member] | Investment in Alpha Tau's shares [Member]    
Investments at fair value (see note 4):    
Investments at fair value 215,739 71,623
Level 1 [Member] | Loan to an equity method investee [Member]    
Investments at fair value (see note 4):    
Investments at fair value
Level 1 [Member] | Convertible note [Member]    
Investments at fair value (see note 4):    
Investments at fair value  
Level 1 [Member] | Investment in Shares [Member]    
Investment in associate at fair value- Lifeward (see note 9):    
Investment in associates at fair value 8,252  
Level 1 [Member] | Investment in A&R Pre-Funded Warrants [Member]    
Investment in associate at fair value- Lifeward (see note 9):    
Investment in associates at fair value  
Level 1 [Member] | Investment in A&R Warrants [Member]    
Investments at fair value (see note 4):    
Investments at fair value  
Level 1 [Member] | Investment in A&R Note and Note Warrants [Member]    
Investments at fair value (see note 4):    
Investments at fair value  
Level 2 [Member]    
Investments at fair value (see note 4):    
Investments at fair value  
Investment in associate at fair value- Lifeward (see note 9):    
Investment in associates at fair value 6,640  
Level 2 [Member] | DNA [Member]    
Marketable Securities (see note 3):    
Marketable Securities
Level 2 [Member] | Entera [Member]    
Marketable Securities (see note 3):    
Marketable Securities  
Level 2 [Member] | Pelthos [Member]    
Marketable Securities (see note 3):    
Marketable Securities  
Level 2 [Member] | Nano [Member]    
Marketable Securities (see note 3):    
Marketable Securities
Level 2 [Member] | Ruby Capital [Member]    
Investments at fair value (see note 4):    
Investments at fair value  
Level 2 [Member] | Scilex Royalty Purchase Agreement [Member]    
Investments at fair value (see note 4):    
Investments at fair value
Level 2 [Member] | Scilex Tranche A Note [Member]    
Investments at fair value (see note 4):    
Investments at fair value
Level 2 [Member] | Scilex Tranche B Note [Member]    
Investments at fair value (see note 4):    
Investments at fair value
Level 2 [Member] | Scilex Warrants Note B [Member]    
Investments at fair value (see note 4):    
Investments at fair value
Level 2 [Member] | Investment in Alpha Tau's warrants [Member]    
Investments at fair value (see note 4):    
Investments at fair value
Level 2 [Member] | Warren at Bay Loan [Member]    
Investments at fair value (see note 4):    
Investments at fair value  
Level 2 [Member] | 83 Wythe Loan [Member]    
Investments at fair value (see note 4):    
Investments at fair value  
Level 2 [Member] | Profit Sharing Loan Agreement [Member]    
Investments at fair value (see note 4):    
Investments at fair value
Level 2 [Member] | Loan agreement measured in fair value [Member]    
Investments at fair value (see note 4):    
Investments at fair value
Level 2 [Member] | Investment in Alpha Tau's shares [Member]    
Investments at fair value (see note 4):    
Investments at fair value
Level 2 [Member] | Loan to an equity method investee [Member]    
Investments at fair value (see note 4):    
Investments at fair value
Level 2 [Member] | Convertible note [Member]    
Investments at fair value (see note 4):    
Investments at fair value  
Level 2 [Member] | Investment in Shares [Member]    
Investment in associate at fair value- Lifeward (see note 9):    
Investment in associates at fair value  
Level 2 [Member] | Investment in A&R Pre-Funded Warrants [Member]    
Investment in associate at fair value- Lifeward (see note 9):    
Investment in associates at fair value 6,640  
Level 2 [Member] | Investment in A&R Warrants [Member]    
Investments at fair value (see note 4):    
Investments at fair value  
Level 2 [Member] | Investment in A&R Note and Note Warrants [Member]    
Investments at fair value (see note 4):    
Investments at fair value  
Level 3 [Member]    
Investments at fair value (see note 4):    
Investments at fair value   78,859
Investment in associate at fair value- Lifeward (see note 9):    
Investment in associates at fair value 118,029  
Level 3 [Member] | DNA [Member]    
Marketable Securities (see note 3):    
Marketable Securities
Level 3 [Member] | Entera [Member]    
Marketable Securities (see note 3):    
Marketable Securities  
Level 3 [Member] | Pelthos [Member]    
Marketable Securities (see note 3):    
Marketable Securities  
Level 3 [Member] | Nano [Member]    
Marketable Securities (see note 3):    
Marketable Securities
Level 3 [Member] | Ruby Capital [Member]    
Investments at fair value (see note 4):    
Investments at fair value 449  
Level 3 [Member] | Scilex Royalty Purchase Agreement [Member]    
Investments at fair value (see note 4):    
Investments at fair value 1,749 2,209
Level 3 [Member] | Scilex Tranche A Note [Member]    
Investments at fair value (see note 4):    
Investments at fair value 18,716 23,063
Level 3 [Member] | Scilex Tranche B Note [Member]    
Investments at fair value (see note 4):    
Investments at fair value 4,591 11,473
Level 3 [Member] | Scilex Warrants Note B [Member]    
Investments at fair value (see note 4):    
Investments at fair value 97 850
Level 3 [Member] | Investment in Alpha Tau's warrants [Member]    
Investments at fair value (see note 4):    
Investments at fair value 36,626 6,242
Level 3 [Member] | Warren at Bay Loan [Member]    
Investments at fair value (see note 4):    
Investments at fair value 2,703  
Level 3 [Member] | 83 Wythe Loan [Member]    
Investments at fair value (see note 4):    
Investments at fair value 2,341  
Level 3 [Member] | Profit Sharing Loan Agreement [Member]    
Investments at fair value (see note 4):    
Investments at fair value 3,338 1,890
Level 3 [Member] | Loan agreement measured in fair value [Member]    
Investments at fair value (see note 4):    
Investments at fair value 37,883 27,943
Level 3 [Member] | Investment in Alpha Tau's shares [Member]    
Investments at fair value (see note 4):    
Investments at fair value
Level 3 [Member] | Loan to an equity method investee [Member]    
Investments at fair value (see note 4):    
Investments at fair value 4 553
Level 3 [Member] | Convertible note [Member]    
Investments at fair value (see note 4):    
Investments at fair value   $ 4,636
Level 3 [Member] | Investment in Shares [Member]    
Investment in associate at fair value- Lifeward (see note 9):    
Investment in associates at fair value  
Level 3 [Member] | Investment in A&R Pre-Funded Warrants [Member]    
Investment in associate at fair value- Lifeward (see note 9):    
Investment in associates at fair value  
Level 3 [Member] | Investment in A&R Warrants [Member]    
Investments at fair value (see note 4):    
Investments at fair value 1,675  
Level 3 [Member] | Investment in A&R Note and Note Warrants [Member]    
Investments at fair value (see note 4):    
Investments at fair value $ 7,857